Obesity Drug Labeling Updated with New Interaction, Side Effect

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

The Food and Drug Administration (FDA) has approved a supplemental New Drug Application for Xenical (obesity management drug) regarding new drug interactions and adverse reaction updates to its labeling. Xenical is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. The product labeling has been updated to include a possible drug interaction with amiodarone (treats life-threatening heart rhythm problems). Via MPR. Posted August 17, 2015.

–Alanna McCatty


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

News Scan: Warfarin, A-Fib, Lavender Oil and Dopamine Agonist Medicine

News Scan: Warfarin, A-Fib, Lavender Oil and Dopamine Agonist Medicine

Every so often a lay person like me slaps her forehead and says out loud, “what took so long?” A veggie works better than a medicine, why not use the veggie? Talking to patients in their home leads to better understanding by the patients? Of course. And less intuitive but…

News Scan 9/4/2019: Breast Cancer, Osteoporosis and Cardio Health

News Scan 9/4/2019: Breast Cancer, Osteoporosis and Cardio Health

Less medicine and a little less food are the themes for keeping healthy this week.  Be well.    Breast Cancer and Hormone Treatment In a large study of published studies (meta analysis) that included more than 100,000 women, those who reported ever using MHT had a 26% higher relative risk…